Drug firm Morepen Laboratories on Wednesday said its board has approved raising over Rs 433 crore through the issue of shares to Switzerland’s private venture capital firm Corinth Investment Holdings and Liquid Holdings, a promoter group of the company, on a preferential basis.

“The board of directors of the company considered and approved the issue and allotment of up to 10.85 crore equity shares on a preferential basis,” Morepen Laboratories said in a regulatory filing.

In a separate filing, Morepen Laboratories said the Morepen Group has sealed a total investment of $100 million (about Rs 750 crore) from Corinth Group.

Morepen Laboratories’ board has approved the issuance of up to 5 crore equity shares to Liquid Holdings, an entity belonging to the promoter group of the company, at a price of Rs 38 per equity shares, for an aggregate amount of up to Rs 190 crore.

Morepen Laboratories’ board also approved the issue of up to 5.85 crore equity shares to Corinth Investment Holdings AG, a Switzerland based entity, that belongs to the public category.